Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma.
about
Recurrence after operative management of intrahepatic cholangiocarcinomaThe expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma.Patterns of failure and prognostic factors in resected extrahepatic bile duct cancer: implication for adjuvant radiotherapyCholangiocarcinoma: modern advances in understanding a deadly old diseaseHow to access photodynamic therapy for bile duct carcinoma.Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection.Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.Initial presentation and management of hilar and peripheral cholangiocarcinoma: is a node-positive status or potential margin-positive result a contraindication to resection?Clinical parameters predicting survival duration after hepatectomy for intrahepatic cholangiocarcinoma.NCCN clinical practice guidelines in oncology: hepatobiliary cancersTGF-β1 expression is associated with invasion and metastasis of intrahepatic cholangiocarcinoma.Management of hilar biliary strictures.Routine lymph node dissection may be not suitable for all intrahepatic cholangiocarcinoma patients: results of a monocentric series.Role of liver transplantation in the treatment of cholangiocarcinoma.STAT3 overexpression promotes metastasis in intrahepatic cholangiocarcinoma and correlates negatively with surgical outcomeCurrent research in perineural invasion of cholangiocarcinoma.Lymph node dissection for intrahepatic cholangiocarcinoma: a critical review of the literature to date.Overexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab.The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics.Gab1 regulates proliferation and migration through the PI3K/Akt signaling pathway in intrahepatic cholangiocarcinoma.External radiotherapy and brachytherapy in the management of extrahepatic and intrahepatic cholangiocarcinoma: available evidence.Prognostic factors for survival after curative resection of distal cholangiocarcinoma: perineural invasion and lymphovascular invasion.Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma.Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment success.Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient.Potential diagnostic and prognostic biomarkers for cholangiocarcinoma in serum and bile.Prediction of the postoperative prognosis of intrahepatic cholangiocarcinoma (ICC): importance of preoperatively- determined anatomic invasion level and number of tumorsM3 muscarinic acetylcholine receptors regulate epithelial-mesenchymal transition, perineural invasion, and migration/metastasis in cholangiocarcinoma through the AKT pathway
P2860
Q30412886-363E77F8-2899-4716-B4C2-B0954F0015C6Q33312079-8586C9EE-3440-4304-ACD8-215E1BFAA466Q33923030-5E0F9292-768E-46AE-BF77-7730D13DD502Q34000079-3491B69A-DD54-4D93-B4C1-AB98386E5EC1Q34357752-3EBD9142-EC9A-4BB2-A727-6731F5ABA3C7Q34744836-25AC7632-EE39-4949-B1B3-D87073135F30Q34986048-0FBBFC69-1785-452E-89CC-BA4B9A4A718DQ35079343-FCD93B2D-6E69-4FD4-A808-6F0EE6DD2413Q35569223-5570C366-D923-461F-A5D0-278E44FCBD1DQ35703937-9AE78C8B-350F-4EC5-9F03-D5CFE920FB17Q35885365-F7039894-0905-4716-9277-9FCD1986F2B9Q37009026-C5657340-4124-436A-BF6C-321470F3F5F6Q37408964-40EFEF47-BEFC-4226-AB64-13BD4EAD7C3CQ37449054-1022E04D-F06B-485C-BFE8-4DBB0039BA2EQ37702595-6F94CB70-6F7E-4AAD-AC6B-86BCB20E0C38Q37706677-03AD04B5-F19A-4C47-AB6B-DD438B2BC141Q38136594-644C1834-2C1C-4BAA-B118-E24AF2827A05Q38390565-F8882805-446A-4958-9600-B9CC2792D7E9Q38400584-9EDA05E6-C08F-4633-9D7F-BC54FF31BCC4Q38870567-E360D436-7180-4EE0-BBE1-B5F616671BD1Q39280212-34E26219-90C4-4230-BF6F-39499FF7E484Q44621438-84338276-5489-47B5-B121-BAD928965D0FQ44700131-E3E41D81-9716-4607-83EE-02A55F0EB2EBQ44866763-CF246E97-B52D-43E4-8BC2-4598761E4837Q49178445-2FB866DE-484E-4EBC-965C-BF0A7CF7F073Q51314955-EF95B314-E6E5-4D43-9F5B-38C87EBE2413Q57154434-C170C237-6729-483F-B9BD-5449F6100DA6Q59137529-5DFDF347-503A-41F6-A6D1-578850066877
P2860
Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Aggressive surgical resection ...... trahepatic cholangiocarcinoma.
@ast
Aggressive surgical resection ...... trahepatic cholangiocarcinoma.
@en
Aggressive surgical resection ...... trahepatic cholangiocarcinoma.
@nl
type
label
Aggressive surgical resection ...... trahepatic cholangiocarcinoma.
@ast
Aggressive surgical resection ...... trahepatic cholangiocarcinoma.
@en
Aggressive surgical resection ...... trahepatic cholangiocarcinoma.
@nl
prefLabel
Aggressive surgical resection ...... trahepatic cholangiocarcinoma.
@ast
Aggressive surgical resection ...... trahepatic cholangiocarcinoma.
@en
Aggressive surgical resection ...... trahepatic cholangiocarcinoma.
@nl
P2093
P1476
Aggressive surgical resection ...... trahepatic cholangiocarcinoma.
@en
P2093
Fumihiko Miura
Hirotoshi Kinoshita
Takashi Kenmochi
Takehide Asano
Takenori Ochiai
Tetsuro Urashima
Toshio Nakagohri
P2888
P304
P356
10.1007/S00268-002-6696-7
P577
2003-02-27T00:00:00Z
P6179
1046733162